Servier Arklow an independent international pharmaceutical company, today celebrated its 30th anniversary of manufacturing at its Arklow site, with the support of Ireland’s inward investment promotion agency, the IDA, a non-commercial, semi-state body promoting foreign direct investment into Ireland through a wide range of services. The celebration was led by Minister for Health Simon Harris, Ambassador of France in Ireland, H.E. Stéphane Crouzat, and senior leaders from the Servier Group and IDA Ireland.
“Through this event, we are celebrating 30 years of Servier Group’s long-term commitment in Ireland, demonstrating Servier’s excellence in the production of its medicines,” said Pierre Venesque, Executive Vice President Industry of the Servier Group. “With a strong industrial footprint, wherever we are in the world, we provide patients with medicines of the same quality and therapeutic effectiveness.”
Arklow, the largest production facility outside France for the Servier Group1
Servier (Ireland) Industries Ltd. was established in 1989 and is located in Co. Wicklow. It is now the largest production facility outside France for the Servier Group. Servier Arklow, which has special know-how in manufacturing of oral solid dosage, is diversifying its activity towards the production of highly potent drugs.
The Arklow plant has grown steadily from 12 employees producing 1 million boxes in 1989 to a site of 450 employees producing 160 million boxes in 2019 and exporting to more than 100 countries worldwide. The site is central to the manufacturing of 42 semi-finished products treating indications in the cardiovascular, metabolic, chronic venous disease, and central nervous system areas. Since its creation, 200 M€ has been invested in the Arklow site by the Servier Group.
Augustin Blanc, General Manager of Servier Arklow, declared: “Today I am very proud and happy to celebrate the 30th anniversary of the Servier Arklow site. I would like to thank all our staff on site, who are engaged every day in providing patients around the world with quality medicines. Patients are counting on us and we are committed to continue along this path.”
Leading the celebration, Minister for Health Simon Harris, declared: “Today, you are celebrating 30 years of manufacturing here in Arklow. I want to thank you for your dedication to this area. I also want to acknowledge the important role of IDA, which has worked proactively in supporting Servier over the last 30 years, as well as other developments throughout Ireland. You opened your doors in 1989, and you have grown from strength to strength with 450 people working at the site here. I hope you continue to grow and I look forward to the next 30 years!”
Michael Lohan, Head of Lifesciences & Strategic Property IDA Ireland added: “I would like to congratulate Servier on this significant milestone as they celebrate 30 years of manufacturing in Arklow, and their long-term commitment to Ireland. Servier can be assured of our continued support as they work toward future milestones.”
Servier Arklow has more than 10 years of experience in producing highly potent level 4 products (OEB4). In response to this demand, and in line with Servier’s ambition to become a key player in oncology, Servier Arklow has invested, in 2019, 5 M€ in a new, state-of-the-art, high containment manufacturing facility that enables the site to produce the highest level of potency, meaning OEB5 products.
This new facility offers manufacturing services including granulation, tablet compression, tablet coating, packaging, and analytical services, along with all support services needed to produce the highest potent drugs (EOB5). Through the InnoONE brand, Servier Arklow offers innovative high potent drugs to external partners.